Monitoring the HIV response for trans people in Europe and Central Asia
HIV Medicine · 2026
DOI: 10.1111/hiv.70250 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2026. Verfasst von S North und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rigshospitalet, Centre of Excellence for Health, Immunity and Infections (CHIP), Copenhagen, Denmark. Hauptthemen laut MEDLINE: HIV Infections, Transgender Persons, Health Policy. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: World Health Organization, European Centre for Disease Prevention and Control.
Abstract (Originalsprache)
Objectives
This paper aims to present available data on national responses to HIV for trans populations related to national policies, legal environments and prevention programmes, as reported by European and Central Asian countries.
Methods
Between February and April 2024, the European Centre for Disease Prevention and Control disseminated an online questionnaire to nominated National HIV Focal Points in Europe and Central Asia to monitor implementation of the Dublin Declaration on partnership to fight HIV/AIDS. This included questions on national HIV policies, legal environments, prevention programmes, the continuum of HIV care and avoidance of healthcare.
Results
Twenty‐three of 50 countries involve trans people in the content and development of national HIV strategies and policies related to their health. Two of 47 countries enact punitive legislation against trans people, and there is some evidence of healthcare seeking avoidance among trans people due to stigma in healthcare settings. In half of reporting countries (23/46), trans people have free (no cost) access to sexually transmitted infection testing and treatment. Limited availability and quality of national HIV data on the number of trans people diagnosed, treated and virally suppressed prevent the accurate measurement of progress towards global HIV targets for this key population.
Conclusions
Trans people are to a lesser extent than other key populations addressed in national HIV policies and strategies, and the data available from countries suggest lower levels of access to services because of costs, unsupportive legal environments and avoidance of seeking healthcare services. Without comprehensive and trans‐inclusive data collection, national and regional HIV responses may risk neglecting the specific needs of trans people in HIV prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rigshospitalet, Centre of Excellence for Health, Immunity and Infections (CHIP), Copenhagen, Denmark.
- Trans Europe and Central Asia (TGEU), Berlin, Germany.
- World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
ORCID-Profile: S North, A Rinder Stengaard
Förderung
- World Health Organization
- European Centre for Disease Prevention and Control
Zitieren
APA
North, S., Calderon-Cifuentes, P. A., Raben, D., Bivol, S., Rinder Stengaard, A., & Noori, T. (2026). Monitoring the HIV response for trans people in Europe and Central Asia. HIV Medicine. https://doi.org/10.1111/hiv.70250
Vancouver
North S, Calderon-Cifuentes PA, Raben D, Bivol S, Rinder Stengaard A, Noori T. Monitoring the HIV response for trans people in Europe and Central Asia. HIV Medicine. 2026. doi:10.1111/hiv.70250
BibTeX
@article{North2026,
author = {North, S and Calderon-Cifuentes, P A and Raben, D and Bivol, S and Rinder Stengaard, A and Noori, T},
title = {Monitoring the HIV response for trans people in Europe and Central Asia},
journal = {HIV Medicine},
year = {2026},
doi = {10.1111/hiv.70250}
}
EUVIMED